Breast Cancer
News and reporting on breast cancer.
FDA Approves AstraZeneca, Daiichi Sankyo's Datroway for HR-Positive, HER2-Negative Breast Cancer
This marks the first US approval for AstraZeneca and Daiichi Sankyo's Trop-2-directed antibody drug conjugate.
The firm aims to advance two breast cancer therapies in HR-positive, HER2-negative advanced breast cancer this year.
Eli Lilly to Acquire Scorpion Therapeutics' Mutant PI3Kα Inhibitor for $2.5B
Lilly recently terminated its own mutant PI3Kα inhibitor program following disappointing Phase I results.
African, Asian Ancestry Patients Less Likely to Be Eligible for New Precision Oncology Drugs
Premium
A new study found that fewer African and Asian patients had clinically actionable alterations for lung, breast, and colorectal cancer.
Repare Therapeutics Shuffles Pipeline, Pauses Some Programs Pending Partnership
The firm will pause development of lunresertib and camonsertib while focusing on development of two newer programs.
Dec 19, 2024
Dec 13, 2024
Dec 13, 2024
Nov 25, 2024